Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinoma.

CD24 CD44v3 CSC OSCC immune checkpoint inhibitors programmed cell death 1 programmed cell death ligand 1

Journal

Oncology letters
ISSN: 1792-1082
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 12 09 2023
accepted: 12 12 2023
medline: 22 1 2024
pubmed: 22 1 2024
entrez: 22 1 2024
Statut: epublish

Résumé

The relationship between cancer stem cells (CSCs) in oral squamous cell carcinoma (OSCC) and programmed cell death ligand 1 (PD-L1)/programmed cell death 1 (PD-1) remains unclear. Therefore, the present study aimed to clarify the association between the CD44v3

Identifiants

DOI: 10.3892/ol.2024.14213 PMID: 38249811 PMC: PMC10797318
pubmed: 38249811
doi: 10.3892/ol.2024.14213
pii: OL-27-2-14213
pmc: PMC10797318
doi:

Types de publication

Journal Article

Langues

eng

Pagination

79

Informations de copyright

Copyright: © Todoroki et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Auteurs

Keita Todoroki (K)

Dental and Oral Medical Center, Kurume University, School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Department of Dental and Oral Surgery, Takagi Hospital, Kouhoukai Medical Corporation, Okawa, Fukuoka 831-0016, Japan.

Yushi Abe (Y)

Dental and Oral Medical Center, Kurume University, School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Department of Dental and Oral Surgery, Takagi Hospital, Kouhoukai Medical Corporation, Okawa, Fukuoka 831-0016, Japan.

Katsuhisa Matsuo (K)

Dental and Oral Medical Center, Kurume University, School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Department of Dental and Oral Surgery, Takagi Hospital, Kouhoukai Medical Corporation, Okawa, Fukuoka 831-0016, Japan.

Hidetoshi Nomura (H)

Dental and Oral Medical Center, Kurume University, School of Medicine, Kurume, Fukuoka 830-0011, Japan.

Akihiko Kawahara (A)

Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Fukuoka 830-0011, Japan.

Yoshiaki Nakamura (Y)

Department of Dentistry and Oral Surgery, Oita Saiseikai Hita Hospital, Hita, Oita 877-1292, Japan.

Moriyoshi Nakamura (M)

Dental and Oral Medical Center, Kurume University, School of Medicine, Kurume, Fukuoka 830-0011, Japan.

Naoko Seki (N)

Dental and Oral Medical Center, Kurume University, School of Medicine, Kurume, Fukuoka 830-0011, Japan.

Jingo Kusukawa (J)

Dental and Oral Medical Center, Kurume University, School of Medicine, Kurume, Fukuoka 830-0011, Japan.

Classifications MeSH